The Prognostic Value of Serum Biomarkers in Osteosarcoma

Istituto Ortopedico Rizzoli

Status: Completed

Conditions: Osteosarcoma

Treatments: Other: case series review of clinical data

Study type: Observational

Funder types: Other

Identifiers

NCT05093101

ProOsteo

Details and patient eligibility

About

Observational retrospective cohort study using laboratory data of blood tests prior to surgical and chemotherapy treatment and other histologic, clinical, and instrumental data related to patient history from digitized medical records and analysis of the same as predictors of outcomes.

Enrollment: 600 patients

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Osteosarcoma diagnosed at the Pathological Anatomy of the Rizzoli Orthopaedic Institute in Bologna;
• Minimum 2-year follow-up period;
• Medical records, complete blood work and instrumental examinations, regular follow-up;
• Patients with age ≥ 2 years;

Exclusion criteria

• Patients with osteosarcoma who have received medical treatment (surgery, radiotherapy or chemotherapy) in other hospitals prior to admission to our Institute